Feed aggregator

Experimental drug turns cancer’s favorite fuel - sugar - against it

World Pharma News - Fri, 08/14/2026 - 10:00
Cancer cells have a voracious appetite for sugar - using it to fuel their rapid growth. This is why many scientists have tried to develop drugs that block cancer cells’ metabolism by cutting off their sugar supply.

Now a team led by researchers at The University of Texas at Austin report in the journal Nature Chemical Biology that they have found a completely different approach. Instead of starving cancer cells, they trick them into consuming even more sugar than usual.

A promising solution to a cancer drug resistance problem

World Pharma News - Thu, 08/13/2026 - 10:00
A protein that can dial down oxidative stress in cells helps some cancers resist treatment with a widely used class of drugs called BTK inhibitors, according to a study led by investigators at Weill Cornell Medicine. The discovery points to a possible solution to the problem of BTK inhibitor treatment resistance.

BTK inhibitors reduce the activity of the enzyme BTK (Bruton’s Tyrosine Kinase), which has a central role in immune cells called B cells.

Viagra may reduce cancer metastasis

World Pharma News - Wed, 08/12/2026 - 10:00
Viagra was originally developed to treat high blood pressure and chest pain caused by reduced blood flow to the heart, but over the past three decades it has become the world’s best-known therapy for erectile dysfunction. In the future, this blockbuster drug may find yet another use. In a study published recently in Cancer Research, scientists in the lab of Prof. Ayelet Erez at the Weizmann Institute of Science found that sildenafil, Viagra’s active ingredient, may restrict cancer metastasis through a newly discovered biological mechanism.

Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI

World Pharma News - Tue, 08/11/2026 - 10:00
Abbott (NYSE: ABT) today announced a first-of-its-kind partnership with Google Health to redefine how people understand and manage their health. By combining glucose insights from Abbott's Lingo biowearable with Google's expertise in artificial intelligence (AI) and consumer technology, the multi-year collaboration makes personalized metabolic insights more actionable, helping people take a more proactive approach to their health.

New approach to the development of non-opioid painkillers

World Pharma News - Mon, 08/10/2026 - 10:00
An international research team led by the Medical University of Vienna has investigated a new peptide derived from cone snail venom which significantly reduced inflammation-induced pain in an animal model. Crucially, its effect takes hold immediately after subcutaneous injection, whereas previously known cone snail peptides must be administered directly into the cerebrospinal fluid.

More than half of U.S. adults now eligible for statins under new guidelines

World Pharma News - Fri, 08/07/2026 - 10:00
More than half of U.S. adults ages 30 to 79 - about 87.5 million people - are now recommended for statins to prevent cardiovascular disease under newly updated clinical guidelines, according to a study by University of Pittsburgh School of Medicine researchers published in JAMA.

The new recommendations significantly change how doctors assess cardiovascular risk by looking beyond the next 10 years to a person’s risk over several decades.

Many countries overusing powerful antibiotics

World Pharma News - Thu, 08/06/2026 - 10:00
Many countries are using too many powerful and inappropriate antibiotics, fuelling antibiotic resistance concerns, while millions lack access to the specific drugs they need. That is according to a major international study of antibiotic use published in The Lancet Public Health.

Research led by City St George's, University of London and University of Oxford developed the first global framework that estimates how many and which type of antibiotics each country needs to treat their infections.

GLP-1 diabetes drugs linked to increased risk of hair loss

World Pharma News - Wed, 08/05/2026 - 10:00
Use of glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity are associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, finds a study published by The BMJ.

Although the absolute risk is low, awareness of this potential effect may help to inform shared treatment decisions, say the researchers.

Study reveals structure of brain protein and identifies potential drug target for epilepsy research

World Pharma News - Tue, 08/04/2026 - 10:00
Scientists at the Icahn School of Medicine at Mount Sinai have uncovered the first high-resolution structure of NBCn2, a brain protein linked to epilepsy, autism spectrum disorder, and other neurological conditions, and developed the first compounds capable of inhibiting its activity. The findings provide a new framework for studying how altered brain signaling contributes to disease and may help advance future therapeutic research.

A secret weapon against superbugs

World Pharma News - Mon, 08/03/2026 - 10:00
Antibiotic resistance has quietly become one of the greatest threats to global healthcare. Each year, drug-resistant bacteria claim lives by rendering once-reliable antibiotics ineffective, turning routine surgeries, cancer treatments, and even common infections into potentially life-threatening events.

Scientists around the world are racing to find new ways to stay ahead of these evolving pathogens. The answer may not lie in discovering an entirely new antibiotic, but in reinventing the chemistry behind the ones we already have.

Immutep Aces Phase IIb in First-Line Head and Neck Cancer, Eyes Regulatory Path Ahead

Biospace news - Sat, 12/07/2024 - 02:00
Immutep Aces Phase IIb in First-Line Head and Neck Cancer, Eyes Regulatory Path Ahead 7/12/2024

Senate Unanimously Passes Bill to Reduce Big Pharma Patent Thickets, Increase Competition

Biospace news - Sat, 12/07/2024 - 02:00
Senate Unanimously Passes Bill to Reduce Big Pharma Patent Thickets, Increase Competition 7/12/2024

AbbVie’s Humira Continues to Lose Market Share as Biosimilars Gain Ground: Report

Biospace news - Sat, 12/07/2024 - 02:00
AbbVie’s Humira Continues to Lose Market Share as Biosimilars Gain Ground: Report 7/12/2024

Akebia Ends Deal With CSL Vifor, Unveils Hefty Price Tag for CKD Anemia Drug Vafseo

Biospace news - Sat, 12/07/2024 - 02:00
Akebia Ends Deal With CSL Vifor, Unveils Hefty Price Tag for CKD Anemia Drug Vafseo 7/12/2024

PBMs and Big Pharma Play Blame Game for Inflated Prescription Drug Prices

Biospace news - Sat, 12/07/2024 - 02:00
PBMs and Big Pharma Play Blame Game for Inflated Prescription Drug Prices 7/12/2024

Biopharma Layoff Tracker 2024: Spark, Novartis, Indivior and More Cut Staff

Biospace news - Sat, 12/07/2024 - 02:00
Biopharma Layoff Tracker 2024: Spark, Novartis, Indivior and More Cut Staff 7/12/2024

FDA Decision Tracker: Novo’s Once-Weekly Insulin Icodec Rejected

Biospace news - Sat, 12/07/2024 - 02:00
FDA Decision Tracker: Novo’s Once-Weekly Insulin Icodec Rejected 7/12/2024

EMA Finds No Link Between GLP-1 Drugs and Suicidal Thoughts, Self-Harm

Biospace news - Wed, 12/04/2024 - 02:00
EMA Finds No Link Between GLP-1 Drugs and Suicidal Thoughts, Self-Harm 4/12/2024

EC Approves Illumina’s Plan to Divest Cancer Diagnostics Maker Grail

Biospace news - Wed, 12/04/2024 - 02:00
EC Approves Illumina’s Plan to Divest Cancer Diagnostics Maker Grail 4/12/2024

AACR, Cancer Treatment and the Promise of Antibody-Drug Conjugates

Biospace news - Wed, 12/04/2024 - 02:00
AACR, Cancer Treatment and the Promise of Antibody-Drug Conjugates 4/12/2024